Benzinga's Top #PreMarket Gainers
August 26, 2014 at 08:11 AM EDT
Kite Pharma (NASDAQ: KITE) jumped 19.06% to $26.55 in pre-market trading on positive non-Hodgkin's lymphoma trial results using KTE-C19. ...
Benzinga's Top #PreMarket GainersAugust 26, 2014 at 08:11 AM EDT
Kite Pharma (NASDAQ: KITE) jumped 19.06% to $26.55 in pre-market trading on positive non-Hodgkin's lymphoma trial results using KTE-C19. ...
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|